Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.39
-0.21 (-1.81%)
At close: Jun 27, 2025, 4:00 PM
11.35
-0.04 (-0.35%)
Pre-market: Jun 30, 2025, 8:00 AM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $7.74 billion as of June 30, 2025. Its market cap has decreased by -0.84% in one year.
Market Cap
7.74B
Enterprise Value
2.96B
1-Year Change
-0.84%
Ranking
Category
Stock Price
$11.39
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $7.74B, an increase of 1,351.69%. That is a compound annual growth rate of 79.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 7.74B | -10.09% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |